Denver, COFounded 202025+ employeesPrivate
$24.5M raisedSeries A· last: series a (Oct 2023)· 4 rounds
Backed by(25 investors)
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
